M
Meghan A. Jobson
Researcher at University of North Carolina at Chapel Hill
Publications - 11
Citations - 318
Meghan A. Jobson is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Excitatory postsynaptic potential & Denatonium. The author has an hindex of 7, co-authored 11 publications receiving 257 citations. Previous affiliations of Meghan A. Jobson include University of Utah & Duke University.
Papers
More filters
Journal ArticleDOI
Transgenerational Effects of Early Life Starvation on Growth, Reproduction, and Stress Resistance in Caenorhabditis elegans
Meghan A. Jobson,James M. Jordan,Moses A. Sandrof,Jonathan D. Hibshman,Ashley L. Lennox,L. Ryan Baugh +5 more
TL;DR: The results demonstrate that starvation affects a variety of life-history traits in the exposed animals and their descendants, some presumably reflecting fitness costs but others potentially adaptive.
Journal ArticleDOI
Risk factors for persistent dysphagia after anterior cervical spine surgery.
TL;DR: Data confirm previous reports that dysphagia symptoms persist in a significant proportion of patients more than 1 year after anterior cervical spine surgery, including smoking and pain severity.
Journal ArticleDOI
Spillover transmission is mediated by the excitatory GABA receptor LGC-35 in C. elegans.
Meghan A. Jobson,Christopher M. Valdez,Jann W. Gardner,L. Rene Garcia,Erik M. Jorgensen,Erik M. Jorgensen,Asim A. Beg +6 more
TL;DR: It is demonstrated that both direct and indirect excitatory GABA signaling plays important roles in regulating neuronal circuit function and behavior in C. elegans.
Journal ArticleDOI
Decreasing time to antibiotics in febrile patients with central lines in the emergency department.
Meghan A. Jobson,Moses A. Sandrof,Timothy Valeriote,Abigail L. Liberty,Christine M. Walsh-Kelly,Cheryl L. Jackson +5 more
TL;DR: An emergency department improvement initiative to deliver antibiotics to 90% of patients within 60 minutes for a sustained period of at least 24 months, decreased process variation and mean time to antibiotic administration, and eliminated race-based discrepancies in care was exceeded.
Journal ArticleDOI
Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.
Fernanda Payan Schober,Meghan A. Jobson,Caroline J. Poulton,Harsharan K. Singh,Volker Nickeleit,Ronald J. Falk,J. Charles Jennette,Patrick H. Nachman,William F. Pendergraft +8 more
TL;DR: Fibrillary glomerulonephritis represents a secondary glomerular disease process (associated with autoimmune disease, infection or malignancy) in many cases and hence screening is essential and treatment of underlying disease is essential.